The treatment of Acne Vulgaris
Phase 3
- Conditions
- Acne Vulgaris.Acne vulgaris
- Registration Number
- IRCT138706231245N1
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 96
Inclusion Criteria
Presence of mild to moderate Acne Vulgaris (up to 10 comedons, papular and/or pustular lesions). Exclusion criteria: pregnant and breast feeding women, children younger than 10 years old, severe cases of acne (existence of nodules and cysts), receiving anti acne during four weeks prior to study, taking acne creating drugs such as oral or local steroids, vitamin B12, anticonvulsive drugs.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Inflammatory and noninflammatory lesions. Timepoint: Baseline and after 2,4,8, and 12 weeks. Method of measurement: counting lesions using manual lens.
- Secondary Outcome Measures
Name Time Method Reduction of lesions inflammatory and noninflammatory. Timepoint: Baseline and after 2, 4, 6, and 8 weeks. Method of measurement: ASI formula and total count rate.